SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
43 hedge funds and large institutions have $154M invested in Sienna Biopharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+9
Holders Change %
+26.47%
% of All Funds
0.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
12
Increased
18
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$5.08M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.27M |
| 3 |
Morgan Stanley
New York
|
+$1.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$820K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$617K |
